Burning Rock Schedules Second Quarter of 2021 Earnings Release on August 31, 2021

NEXT STORY
Global DNA Sequencing: Research, Applied and Clinical Markets
PREV STORY
Abcam to Acquire BioVision for $340 million
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Atreca to Present at the Cowen and Company 40th Annual Health Care Conference

author_avatar
NASDAQ Market News

SEngine Precision Medicine to Present Data Related to the Predictive Value of the PARIS® Test for Oncology Drugs Based on Retrospective Analysis at 2020 ASCO Annual Meeting

author_avatar
NASDAQ Market News

Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer’s disease (AD) – other company programmes in AD continue

The Alzheimer's Prevention Initiative (API) study of crenezumab in familial Alzheimer's disease continues Roche ...

author_avatar
NASDAQ Market News